跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACCEL-CANDESARTAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACCEL-CANDESARTAN
Authorized
STANDARD
ACCEL-CANDESARTAN
accel pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a7c2077edf4e7868
Company
accel pharma inc
Type
Standard
Approval Details
Approval Id
a7c2077edf4e7868
Drug Approval Canada Name
ACCEL-CANDESARTAN
Product Name
ACCEL-CANDESARTAN
Status
Cancelled Post Market
Status Date
2020-03-05
Original Market Date
2017-12-27
Din
02463768
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.08
Atc Original
C09CA06 CANDESARTAN
Atc Name
c 09 ca 06
Aig Number
0135220002
Company Name
accel pharma inc
Company Address
119 Labrosse Ave, Pointe Claire, Quebec, Canada, H9R 1A3
Active Ingredients
CANDESARTAN CILEXETIL
8 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a7c2077edf4e7868
Type
Standard
Back to Health Canada Approvals